WITNESS: Ending Breast Cancer with the Department of Defense

The BCRP enables researchers to propose their best, innovative ideas that address the urgent need to end breast cancer. Scientists are challenged to pursue high-risk/high-reward research, explore new paradigms that could lead to critical discoveries, and make an unprecedented impact on breast cancer.

By The Department of Defense

The Office of the Congressionally Directed Medical Research Programs (CDMRP) was created in 1992 from a powerful grassroots effort led by the breast cancer advocacy community that resulted in a congressional appropriation of funds for breast cancer research. This initiated a unique partnership among the public, Congress, and the military. Since then, the CDMRP has grown to encompass multiple targeted programs and has received over $8.2 billion (B) in appropriations from its inception through fiscal year 2014 (FY14). Funds for the CDMRP are added to the Department of Defense (DoD) budget, in which support for individual programs, such as the Breast Cancer Research Program (BCRP), is allocated via specific guidance from Congress. READ THE FULL REPORT

Image: A Hela cervical cancer cell, photographed by a scanning electron microscope Image Credit: National Institutes of Health (NIH)